Impact of body weight-based dosing of palonosetron and ondansetron on postoperative nausea and vomiting following laparoscopic sleeve gastrectomy: a randomized, double-blind study.

Büşra Burcu Nadir Adnan Hacim Ozan Çalişkan Serdar Demirgan Talar Vartanoglu Aktokmakyan Serhat Meric Tomris Duymaz Onder Karabay Ali Solmaz

Published in: Acta chirurgica Belgica (2023)

The use of palonosetron significantly reduced the incidence of PONV following laparoscopic sleeve gastrectomy. There was a significant improvement in the scores of Functional Living Index-Emesis in patients using palonosetron.

Keyphrases

body weight
chemotherapy induced
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
double blind
patients undergoing
clinical trial
prognostic factors
peritoneal dialysis
randomized controlled trial
patient reported outcomes
study protocol
open label
phase iii